Skip to main content
ZJAMP Group Co., Ltd. logo

ZJAMP Group Co., Ltd. — Investor Relations & Filings

Ticker · 002758 ISIN · CNE100002029 LEI · 3003009OKT32LB5C0T64 Shenzhen Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 1,563 across all filing types
Latest filing 2018-06-11 Capital/Financing Update
Country CN China
Listing Shenzhen Stock Exchange 002758

About ZJAMP Group Co., Ltd.

https://www.znjtgf.com

ZJAMP Group Co., Ltd. specializes in the comprehensive distribution and supply chain management of agricultural production materials. The company’s core operations encompass the procurement, storage, and sale of essential inputs, including chemical fertilizers such as urea, potash, and compound fertilizers, as well as pesticides, seeds, and agricultural machinery. Beyond product distribution, the organization provides integrated technical services, modern logistics solutions, and agricultural consultancy to enhance crop yields and farming efficiency. By leveraging an extensive network of distribution centers and service stations, the group facilitates the stable supply of high-quality agricultural resources. Its business model focuses on bridging the gap between manufacturers and end-users through efficient resource allocation and value-added services.

Recent filings

Filing Released Lang Actions
公开发行可转换公司债券发行公告
Capital/Financing Update Classification · 100% confidence The document is a detailed announcement regarding the public issuance of convertible corporate bonds by Zhejiang Huatong Pharmaceutical Co., Ltd. It includes comprehensive information about the bond issuance such as the type of securities, issuance scale, pricing, interest rates, conversion terms, redemption and repurchase clauses, credit rating, guarantee arrangements, issuance schedule, subscription methods, and underwriting details. The document references regulatory approvals, issuance dates, subscription rules, and listing plans. It is not a financial report like an annual or interim report, nor is it a transcript, management report, or legal proceeding update. It is a formal announcement about a capital raising event through convertible bond issuance, including detailed terms and conditions. Therefore, it fits the category of Capital/Financing Update (CAP). The document length and detail confirm it is the announcement itself, not a brief notice or a report publication announcement.
2018-06-11 Chinese
公开发行可转换公司债券募集说明书
Capital/Financing Update Classification · 95% confidence The document is titled as a "公开发行可转换公司债券募集说明书" which translates to "Public Offering Convertible Corporate Bond Prospectus". It contains detailed information about the convertible bond issuance, including risk factors, credit ratings, guarantee matters, dividend policies, investment risks, and company commitments related to the bond issuance. The document is lengthy (15,000 characters) and includes comprehensive financial and operational details related to the bond offering. This type of document is a detailed offering prospectus related to capital raising through convertible bonds, which fits the category of Capital/Financing Update (CAP). It is not an annual or interim report, nor an earnings release or regulatory filing. It is a primary document describing a capital raising event and related financial and risk disclosures.
2018-06-11 Chinese
钱木水、沈剑巢、朱国良与华金证券股份有限公司关于公司公开发行可转换公司债券之股份质押协议
Regulatory Filings
2018-06-11 Chinese
上海市广发律师事务所关于公司公开发行可转换公司债券的补充法律意见（一）
Regulatory Filings Classification · 95% confidence The document is a detailed legal opinion issued by a law firm regarding the public issuance of convertible corporate bonds by Zhejiang Huatong Pharmaceutical Co., Ltd. It includes legal verification of the bond issuance, guarantees, compliance with regulatory requirements, and administrative penalties related to the company. The document references Chinese securities laws, regulations, and specific administrative feedback from the China Securities Regulatory Commission. It is a legal opinion supplementing previous legal opinions and reports related to the bond issuance. This type of document is not a financial report, earnings release, or management discussion, but rather a legal and regulatory compliance report related to a capital market transaction. Therefore, it fits best under the category of Regulatory Filings (RNS), which covers general regulatory announcements, compliance documents, and miscellaneous filings that do not fit other categories. The document is lengthy (over 14,000 characters) and contains substantive content, not just an announcement or certification, so it is not RPA or a certification filing. Hence, the classification is RNS with high confidence.
2018-06-11 Chinese
上海市广发律师事务所关于公司公开发行可转换公司债券的法律意见
Capital/Financing Update Classification · 95% confidence The document is a detailed legal opinion issued by a law firm regarding Zhejiang Huatong Pharmaceutical Co., Ltd.'s public issuance of convertible corporate bonds. It extensively references Chinese securities laws, company law, regulatory approvals, audit reports, financial conditions, and compliance with issuance requirements. The content focuses on the legal and regulatory compliance aspects of a capital raising activity involving convertible bonds. It is not a financial report, earnings release, or management discussion, but a legal opinion related to a capital market transaction. Therefore, the document fits best under the category of Capital/Financing Update (CAP), which covers updates on company fundraising and financing activities.
2018-06-11 Chinese
股票交易异常波动公告
Regulatory Filings Classification · 95% confidence The document is a stock trading abnormal fluctuation announcement by Zhejiang Huatong Pharmaceutical Co., Ltd. It discusses the unusual stock price movements over two trading days, clarifies that no undisclosed material information exists, and provides risk warnings to investors. It references prior announcements about convertible bond issuance and shareholder pledges but does not contain financial statements or detailed financial data. The document is short (1654 characters) and serves as a regulatory disclosure about stock price behavior rather than a financial report or earnings release. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance disclosures that do not fit other categories.
2018-05-28 Chinese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.